https://bayernkapital.de/portfolio/success-stories/tubulis/
Tubulis | Bayern Kapital
bayern kapitaltubulis
https://bayernkapital.de/news-events/308-millionen-euro-fuer-tubulis-in-series-c-finanzierungsrunde-bayern-kapital-beteiligt-sich-erneut-an-dem-biotech-pionier-im-bereich-der-krebsbehandlung/
308 Millionen Euro für Tubulis in Series-C-Finanzierungsrunde: Bayern Kapital beteiligt sich...
millionen euroseries ctubulis
https://www.eu-startups.com/2025/10/munich-based-tubulis-secures-e308-million-to-advance-antibody-drug-conjugate-innovation/
Munich-based Tubulis secures €308 million to advance antibody-drug conjugate innovation |...
Oct 15, 2025 - German biotech company Tubulis has raised €308 million in a record-breaking Series C funding round, marking the largest Series C ever closed by a European
antibody drugmunichbased
https://www.htgf.de/en/htgf-portfolio-company-tubulis-raises-e308m/
HTGF Portfolio Company Tubulis Raises €308M
Oct 15, 2025 - Tubulis, a pioneer in the development of uniquely matched ADCs, announced the successful closing of a €308 million Series C financing round.
htgf portfoliocompanytubulis